FocusAsthma

T cell types that take your breath away

See allHide authors and affiliations

Science Translational Medicine  19 Aug 2015:
Vol. 7, Issue 301, pp. 301fs33
DOI: 10.1126/scitranslmed.aac9737

Figures

  • Fig. 1 Divide and conquer.

    As researchers developed new technologies and defined new biomarkers, a population of asthma patients (gray) has been subdivided, first into TH2-high (purple) and TH2-low (blue) groups. A TH17-high group has now emerged, possibly from the TH2-low group. Also shown are a recently identified interferon-γ (IFN-γ)–high group (black) (19) and a yet-to-be-subdivided group (yellow). In the future, additional groups will be defined, with the ultimate goal of precision medicine in an individual asthma patient (orange). GWAS, genome-wide association studies.

    CREDIT: V. ALTOUNIAN/SCIENCE TRANSLATIONAL MEDICINE

Stay Connected to Science Translational Medicine

Navigate This Article